Table 2.

Prevalence of rare RNASEL and MSR1 sequence variants in prostate cancer patients and controls

Gene	Sequence Variant (Base Pair)	Amino Acid Change	Controls (N = 245) [No. (%)]	Cases (N = 113) [No. (%)]
MSR1	171 C>T	Y57Y	—	1
	IVS2-10 A>G	None	5 (2%)	3 (3%)
	IVS7+35 G>A	None	—	2 (2%)
RNASEL	147_159dupCAAT	V51QfsX2	2 (1%)	—
	1078 A>G	K360E	1 (1%)	—
	1260 C>T	F420F	1 (1%)	—
	IVS1+59 A>G		4 (2%)	3 (3%)
	IVS4+77 T>C		3 (1%)	1 (1%)
	IVS5-27 T>C		2 (1%)	—
	3′UTR2272 G>A		1 (1%)	1

^*Deviates significantly from HWE (P <0.05) None deviate from HWE.